Similar articles for PMID: 29715154

Year	Number of Results
1993	1
1995	1
1996	1
1997	3
2000	2
2001	5
2002	2
2003	4
2004	5
2005	3
2006	4
2007	1
2008	1
2009	6
2010	8
2011	11
2012	12
2013	5
2014	4
2015	7
2016	5
2017	2
2018	1
2019	1
2021	0

1

Radiotherapy Plus Total Androgen Block Versus Radiotherapy Plus LHRH Analog Monotherapy for Non-metastatic Prostate Cancer.

Marvaso G, Viola A, Fodor C, Jereczek-Fossa BA. Marvaso G, et al. Anticancer Res. 2018 May;38(5):3139-3143. doi: 10.21873/anticanres.12576. Anticancer Res. 2018. PMID: 29715154

2

A combination therapy of dexamethasone and somatostatin analog reintroduces objective clinical responses to LHRH analog in androgen ablation-refractory prostate cancer patients.

Koutsilieris M, Mitsiades C, Dimopoulos T, Ioannidis A, Ntounis A, Lambou T. Koutsilieris M, et al. J Clin Endocrinol Metab. 2001 Dec;86(12):5729-36. doi: 10.1210/jcem.86.12.8119. J Clin Endocrinol Metab. 2001. PMID: 11739429

3

Higher sexual interest with androgen receptor inhibitor monotherapy than with castration plus an androgen receptor inhibitor in prostate cancer patients treated with curative radiotherapy, but otherwise small health-related quality of life differences: A randomised prospective 18-month follow-up study.

Majumder K, Nilsson S, Johansson H, Ullén A, Lennernäs B, Bergenmar M, Brandberg Y. Majumder K, et al. Eur J Cancer. 2016 Sep;65:43-51. doi: 10.1016/j.ejca.2016.06.011. Epub 2016 Jul 25. Eur J Cancer. 2016. PMID: 27459586 Clinical Trial.

4

Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate cancer treated with radiotherapy.

Nanda A, Chen MH, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin M, Ross R, D'Amico AV. Nanda A, et al. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1439-44. doi: 10.1016/j.ijrobp.2009.03.034. Epub 2009 Jun 18. Int J Radiat Oncol Biol Phys. 2010. PMID: 19540066

5

Duration of androgen suppression in the treatment of prostate cancer.

Bolla M, de Reijke TM, Van Tienhoven G, Van den Bergh AC, Oddens J, Poortmans PM, Gez E, Kil P, Akdas A, Soete G, Kariakine O, van der Steen-Banasik EM, Musat E, Piérart M, Mauer ME, Collette L; EORTC Radiation Oncology Group and Genito-Urinary Tract Cancer Group. Bolla M, et al. N Engl J Med. 2009 Jun 11;360(24):2516-27. doi: 10.1056/NEJMoa0810095. N Engl J Med. 2009. PMID: 19516032 Free article. Clinical Trial.

6

Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma.

Samson DJ, Seidenfeld J, Schmitt B, Hasselblad V, Albertsen PC, Bennett CL, Wilt TJ, Aronson N. Samson DJ, et al. Cancer. 2002 Jul 15;95(2):361-76. doi: 10.1002/cncr.10647. Cancer. 2002. PMID: 12124837 Free article. Review.

7

Randomized comparison of total androgen blockade alone versus combined with weekly epirubicin in advanced prostate cancer.

Pummer K, Lehnert M, Stettner H, Hubmer G. Pummer K, et al. Eur Urol. 1997;32 Suppl 3:81-5. Eur Urol. 1997. PMID: 9267791 Clinical Trial.

8

Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer.

Lu L, Peters J, Roome C, Stein K. Lu L, et al. BJU Int. 2012 Apr;109(8):1183-92. doi: 10.1111/j.1464-410X.2011.10434.x. Epub 2011 Aug 23. BJU Int. 2012. PMID: 21883830

9

Combined androgen blockade with bicalutamide for advanced prostate cancer: long-term follow-up of a phase 3, double-blind, randomized study for survival.

Akaza H, Hinotsu S, Usami M, Arai Y, Kanetake H, Naito S, Hirao Y; Study Group for the Combined Androgen Blockade Therapy of Prostate Cancer. Akaza H, et al. Cancer. 2009 Aug 1;115(15):3437-45. doi: 10.1002/cncr.24395. Cancer. 2009. PMID: 19536889 Free article. Clinical Trial.

10

Neoadjuvant hormone therapy for radical prostate radiotherapy: bicalutamide monotherapy vs. luteinizing hormone-releasing hormone agonist monotherapy: a single-institution matched-pair analysis.

McGivern U, Mitchell DM, McDowell C, O'Hare J, Corey G, O'Sullivan JM. McGivern U, et al. Clin Genitourin Cancer. 2012 Sep;10(3):190-5. doi: 10.1016/j.clgc.2012.04.003. Epub 2012 Jun 5. Clin Genitourin Cancer. 2012. PMID: 22677511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed